BNTC Earnings & Financial Statements
Benitec Biopharma Inc.
$8.75
-$0.24(-2.67%)
37
Overall
60
Value
18
Tech
34
Quality
Market Cap
$305.22M
Volume
234.86K
52W Range
$8.92 - $16.76
Target Price
$24.33
BNTC earnings and financial statements: Benitec Biopharma Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
BNTC Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | - | - | $75.0K | $73.0K | $59.0K |
| Cost of revenue | - | - | - | $9.0K | - |
| Operating income | -$41.77M | -$22.49M | -$19.08M | -$17.85M | -$13.60M |
| EBITDA | -$41.14M | -$22.57M | -$19.18M | -$17.78M | -$13.21M |
| Net income | -$37.92M | -$21.75M | -$19.56M | -$18.21M | -$13.88M |
| EPS (diluted) | $-1.05 | $-5.51 | $-14.12 | $-37.91 | $-54.91 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BNTC | $8.75 | -2.7% | 234.86K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |